[1] |
CARRIER AN, VERMA A, MOHIUDDIN M, et al. Xenotransplantation: a new era[J]. Front Immunol, 2022, 13: 900594. DOI: 10.3389/fimmu.2022.900594.
|
[2] |
RYCZEK N, HRYHOROWICZ M, ZEYLAND J, et al. CRISPR/Cas technology in pig-to-human xenotransplantation research[J]. Int J Mol Sci, 2021, 22(6): 3196. DOI: 10.3390/ijms22063196.
|
[3] |
PARLAKPINAR H, GUNATA M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs[J]. Immunopharmacol Immunotoxicol, 2021, 43(6): 651-665. DOI: 10.1080/08923973.2021.1966033.
|
[4] |
陶云霞, 石远凯. 霍奇金淋巴瘤免疫逃逸机制及其临床应用价值[J]. 中华肿瘤杂志, 2021, 43(9): 917-923. DOI: 10.3760/cma.j.cn112152-20200623-00591.TAO YX, SHI YK. Immune evasion mechanism and its clinical application value in Hodgkin's lymphoma[J]. Chin J Oncol, 2021, 43(9): 917-923. DOI: 10.3760/cma.j.cn112152-20200623-00591.
|
[5] |
SCHRODER PM, SCHMITZ R, FITCH ZW, et al. Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model[J]. Kidney Int, 2021, 99(1): 161-172. DOI: 10.1016/j.kint.2020.08.020.
|
[6] |
LI XC, ROTHSTEIN DM, SAYEGH MH. Costimulatory pathways in transplantation: challenges and new developments[J]. Immunol Rev, 2009, 229(1): 271-293. DOI: 10.1111/j.1600-065X.2009.00781.x.
|
[7] |
SINGH AK, GOERLICH CE, ZHANG T, et al. CD40-CD40L blockade: update on novel investigational therapeutics for transplantation[J]. Transplantation, 2023, 107(7): 1472-1481. DOI: 10.1097/TP.0000000000004469.
|
[8] |
COOPER DKC, PIERSON RN 3RD. Milestones on the path to clinical pig organ xenotransplantation[J]. Am J Transplant, 2023, 23(3): 326-335. DOI: 10.1016/j.ajt.2022.12.023.
|
[9] |
LA MURAGLIA GM 2ND, ZENG S, CRICHTON ES, et al. Superior inhibition of alloantibody responses with selective CD28 blockade is CTLA-4 dependent and T follicular helper cell specific[J]. Am J Transplant, 2021, 21(1): 73-86. DOI: 10.1111/ajt.16004.
|
[10] |
ESENSTEN JH, HELOU YA, CHOPRA G, et al. CD28 costimulation: from mechanism to therapy[J]. Immunity, 2016, 44(5): 973-988. DOI: 10.1016/j.immuni.2016.04.020.
|
[11] |
LIU D, KRUMMEY SM, BADELL IR, et al. 2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses[J]. J Exp Med, 2014, 211(2): 297-311. DOI: 10.1084/jem.20130902.
|
[12] |
POIRIER N, DILEK N, MARY C, et al. FR104, an antagonist anti-CD28 monovalent Fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft[J]. Am J Transplant, 2015, 15(1): 88-100. DOI: 10.1111/ajt.12964.
|
[13] |
POIRIER N, AZIMZADEH AM, ZHANG T, et al. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation[J]. Sci Transl Med, 2010, 2(17): 17ra10. DOI: 10.1126/scitranslmed.3000116.
|
[14] |
MIURA Y, ISOGAI S, MAEDA S, et al. CTLA-4-Ig internalizes CD80 in fibroblast-like synoviocytes from chronic inflammatory arthritis mouse model[J]. Sci Rep, 2022, 12(1): 16363. DOI: 10.1038/s41598-022-20694-7.
|
[15] |
KHAN M, AROOJ S, WANG H. Soluble B7-CD28 family inhibitory immune checkpoint proteins and anti-cancer immunotherapy[J]. Front Immunol, 2021, 12: 651634. DOI: 10.3389/fimmu.2021.651634.
|
[16] |
HODGSON R, CHRISTIANSEN D, IERINO F, et al. Inducible co-stimulator (ICOS) in transplantation: a review[J]. Transplant Rev (Orlando), 2022, 36(4): 100713. DOI: 10.1016/j.trre.2022.100713.
|
[17] |
XU X, DENNETT P, ZHANG J, et al. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis[J]. J Exp Med, 2023, 220(7): e20221391. DOI: 10.1084/jem.20221391.
|
[18] |
WING K, ONISHI Y, PRIETO-MARTIN P, et al. CTLA-4 control over Foxp3+ regulatory T cell function[J]. Science, 2008, 322(5899): 271-275. DOI: 10.1126/science.1160062.
|
[19] |
李涛, 张侃, 杨文雨, 等. 免疫检查点抑制剂CTLA-4在实体肿瘤治疗中的临床应用[J]. 协和医学杂志, 2023, 14(3): 652-659. DOI: 10.12290/xhyxzz.2022-0617.LI T, ZHANG K, YANG WY, et al. Clinical application of immune checkpoint inhibitors CTLA-4 in solid tumors[J]. Med J Peking Union Med College Hosp, 2023, 14(3): 652-659. DOI: 10.12290/xhyxzz.2022-0617.
|
[20] |
NAKAYAMA Y, WATANABE R, YAMAMOTO W, et al. IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study[J]. Rheumatology (Oxford), 2023, DOI: 10.1093/rheumatology/kead299[Epub ahead of print
|
[21] |
AYAN G, RIBEIRO A, MACIT B, et al. Pharmacologic treatment strategies in psoriatic arthritis[J]. Clin Ther, 2023, 45(9): 826-840. DOI: 10.1016/j.clinthera.2023.05.010.
|
[22] |
KIRK AD, HARLAN DM, ARMSTRONG NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates[J]. Proc Natl Acad Sci U S A, 1997, 94(16): 8789-8794. DOI: 10.1073/pnas.94.16.8789.
|
[23] |
YAKUBU I, MOINUDDIN I, GUPTA G. Use of belatacept in kidney transplantation: what's new?[J]. Curr Opin Organ Transplant, 2023, 28(1): 36-45. DOI: 10.1097/MOT.0000000000001033.
|
[24] |
HIGGINBOTHAM L, MATHEWS D, BREEDEN CA, et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model[J]. Xenotransplantation, 2015, 22(3): 221-230. DOI: 10.1111/xen.12166.
|
[25] |
PHELPS CJ, BALL SF, VAUGHT TD, et al. Production and characterization of transgenic pigs expressing porcine CTLA4-Ig[J]. Xenotransplantation, 2009, 16(6): 477-485. DOI: 10.1111/j.1399-3089.2009.00533.x.
|
[26] |
DIMITRAKOPOULOS FD, KOTTOROU AE, ANTONACOPOULOU AG, et al. Expression of immune system-related membrane receptors CD40, RANK, BAFFR and LTβR is associated with clinical outcome of operated non-small-cell lung cancer patients[J]. J Clin Med, 2019, 8(5): 741. DOI: 10.3390/jcm8050741.
|
[27] |
ZHANG T, PIERSON RN 3RD, AZIMZADEH AM. Update on CD40 and CD154 blockade in transplant models[J]. Immunotherapy, 2015, 7(8): 899-911. DOI: 10.2217/IMT.15.54.
|
[28] |
CHAND DAKAL T, DHABHAI B, AGARWAL D, et al. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders [J]. Immunobiology, 2020, 225(2): 15189. DOI: 10.1016/j.imbio.2019.151899.
|
[29] |
VIAL G, GENSOUS N, DUFFAU P. The CD40-CD40L axis: current and future implications in clinical immunology [J]. Rev Med Interne, 2021, 42(10): 722-728. DOI: 110.1016/j.revmed.2021.02.005.
|
[30] |
TANG T, CHENG X, TRUONG B, et al. Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint [J]. Pharmacol Ther, 2021, 219: 107709. DOI: 10.1016/j.pharmthera.2020.107709.
|
[31] |
PERRIN S, MAGILL M. The inhibition of CD40/CD154 costimulatory signaling in the prevention of renal transplant rejection in nonhuman primates: a systematic review and meta analysis[J]. Front Immunol, 2022, 13: 861471. DOI: 10.3389/fimmu.2022.861471.
|
[32] |
ENELL SMITH K, DERONIC A, HÄGERBRAND K, et al. Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy[J]. Expert Opin Biol Ther, 2021, 21(12): 1635-1646. DOI: 10.1080/14712598.2021.1934446.
|
[33] |
TECTOR AJ, ADAMS AB, TECTOR M. Current status of renal xenotransplantation and next steps[J]. Kidney360, 2023, 4(2): 278-284. DOI: 10.34067/KID.0007152021.
|
[34] |
BÜHLER L, AWWAD M, BASKER M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response[J]. Transplantation, 2000, 69(11): 2296-2304. DOI: 10.1097/00007890-200006150-00013.
|
[35] |
MOHIUDDIN MM, SINGH AK, CORCORAN PC, et al. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO. hCD46Tg pig-to-baboon model[J]. Xenotransplantation, 2014, 21(1): 35-45. DOI: 10.1111/xen.12066.
|
[36] |
HANSEN-ESTRUCH C, BIKHET MH, JAVED M, et al. Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation model[J]. Am J Transplant, 2023, 23(3): 353-365. DOI: 10.1016/j.ajt.2022.11.022.
|
[37] |
OURA T, HOTTA K, LEI J, et al. Immunosuppression with CD40 costimulatory blockade plus rapamycin for simultaneous islet-kidney transplantation in nonhuman primates[J]. Am J Transplant, 2017, 17(3): 646-656. DOI: 10.1111/ajt.13999.
|
[38] |
KIM J, CHOI SH, LEE HJ, et al. Comparative efficacy of anti-CD40 antibody-mediated costimulation blockade on long-term survival of full-thickness porcine corneal grafts in nonhuman primates[J]. Am J Transplant, 2018, 18(9): 2330-2341. DOI: 10.1111/ajt.14913.
|
[39] |
杨树军, 卫浩, 许勇, 等. 六基因编辑猪-食蟹猴异种肾移植围手术期监测初步报道[J]. 器官移植, 2023, 14(4): 521-528. DOI: 10.3969/j.issn.1674-7445.2023.04.008.YANG SJ, WEI H, XU Y, et al. Preliminary report of perioperative monitoring of six-gene-edited pig-to-cynomolgus monkey kidney xenotransplantation[J]. Organ Transplant, 2023, 14(4): 521-528. DOI: 10.3969/j.issn.1674-7445.2023.04.008.
|
[40] |
MIURA S, HABIBABADY ZA, POLLOK F, et al. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival[J]. Am J Transplant, 2023, 23(8): 1182-1193. DOI: 10.1016/j.ajt.2023.03.025.
|
[41] |
HAWTHORNE WJ, SALVARIS EJ, CHEW YV, et al. Xenotransplantation of genetically modified neonatal pig islets cures diabetes in baboons[J]. Front Immunol, 2022, 13: 898948. DOI: 10.3389/fimmu.2022.898948.
|
[42] |
LÄNGIN M, MAYR T, REICHART B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation[J]. Nature, 2018, 564(7736): 430-433. DOI: 10.1038/s41586-018-0765-z.
|
[43] |
IWASE H, JAGDALE A, YAMAMOTO T, et al. Evidence suggesting that deletion of expression of N-glycolylneuraminic acid (Neu5Gc) in the organ-source pig is associated with increased antibody-mediated rejection of kidney transplants in baboons[J]. Xenotransplantation, 2021, 28(4): e12700. DOI: 10.1111/xen.12700.
|
[44] |
COOPER DKC, FOOTE JB, JAVED M, et al. Initial evidence that blockade of the CD40/CD154 costimulation pathway alone is sufficient as maintenance therapy in xenotransplantation[J]. Xenotransplantation, 2021, 28(6): e12721. DOI: 10.1111/xen.12721.
|
[45] |
COGNASSE F, DUCHEZ AC, AUDOUX E, et al. Platelets as key factors in inflammation: focus on CD40L/CD40[J]. Front Immunol, 2022, 13: 825892. DOI: 10.3389/fimmu.2022.825892.
|
[46] |
HASSAN GS, SALTI S, MOURAD W. Novel functions of integrins as receptors of CD154: their role in inflammation and apoptosis [J]. Cells, 2022, 11(11): 1747. DOI: 10.3390/cells11111747.
|
[47] |
SCHULER W, BIGAUD M, BRINKMANN V, et al. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation[J]. Transplantation, 2004, 77(5): 717-726. DOI: 10.1097/01.tp.0000116563.72763.83.
|
[48] |
ROBLES-CARRILLO L, MEYER T, HATFIELD M, et al. Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice[J]. J Immunol, 2010, 185(3): 1577-1583. DOI: 10.4049/jimmunol.0903888.
|
[49] |
BARRILE R, VAN DER MEER AD, PARK H, et al. Organ-on-chip recapitulates thrombosis induced by an anti-CD154 monoclonal antibody: translational potential of advanced microengineered systems [J]. Clin Pharmacol Ther, 2018, 104(6): 1240-1248. DOI: 10.1002/cpt.1054.
|
[50] |
LASSITER G, OTSUKA R, HIROSE T, et al. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival[J]. Am J Transplant, 2023, 23(8): 1171-1181. DOI: 10.1016/j.ajt.2023.03.022.
|
[51] |
FIRL DJ, LASSITER G, HIROSE T, et al. Clinical and molecular correlation defines activity of physiological pathways in life-sustaining kidney xenotransplantation[J]. Nat Commun, 2023, 14(1): 3022. DOI: 10.1038/s41467-023-38465-x.
|
[52] |
ADAMS AB, LOVASIK BP, FABER DA, et al. Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation[J]. Ann Surg, 2021, 274(3): 473-480. DOI: 10.1097/SLA.0000000000004996.
|
[53] |
GRIFFITH BP, GOERLICH CE, SINGH AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation[J]. N Engl J Med, 2022, 387(1): 35-44. DOI: 10.1056/NEJMoa2201422.
|
[54] |
PORRETT PM, ORANDI BJ, KUMAR V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model[J]. Am J Transplant, 2022, 22(4): 1037-1053. DOI: 10.1111/ajt.16930.
|
[55] |
MONTGOMERY RA, STERN JM, LONZE BE, et al. Results of two cases of pig-to-human kidney xenotransplantation[J]. N Engl J Med, 2022, 386(20): 1889-1898. DOI: 10.1056/NEJMoa2120238.
|
[56] |
LOCKE JE, KUMAR V, ANDERSON D, et al. Normal graft function after pig-to-human kidney xenotransplant[J]. JAMA Surg, 2023, 158(10): 1106-1108. DOI: 10.1001/jamasurg.2023.2774.
|